Clinical trial optimization
How can we optimize clinical processes by combining data, analytics and technology to help bring new medications to market faster? Who are the front-runners in doing so? Have we seen new molecules, and rising ROI as a result of the optimization?
Digital Therapeutics: What's next?
We have spoken about DTx several times over the last few years. Now that we accept that DTx have a big role to play in patients' lives, in pharma life-cycles and in the practice of medicine as we know it, what is next on the horizon? Are we being reimbursed as patients and providers, are we building new franchises as pharma, are we identifying common ground in the form of guidelines for evidence building and regulation as DTx companies?
Ask the Investor
Lifting the lid on investments in Digital Health, who are the investors interested in and what partnerships should we keep an eye on.